Corbus Pharmaceutical Holdings, Inc. (CRBP)

[Chess Master]

Climactic reversal today concluded with a gap up intraday from the $8.75 area. The published short interest is just shy of 6.0 million shares so with 45 mil shares out there this represents a big percentage. There is likely a catalyst next week with phase 2 data due to be released. The stock recently hit a closing new high and has given up a month of gains in the past week and is very oversold so this bounce close to support is very constructive. It there is any good news this stock is going to run a lot with such a large short position. Insider buying has been especially strong. So the situation is really looking good.